Floryne O. Buishand

421 total citations
14 papers, 218 citations indexed

About

Floryne O. Buishand is a scholar working on Epidemiology, Oncology and Surgery. According to data from OpenAlex, Floryne O. Buishand has authored 14 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Oncology and 4 papers in Surgery. Recurrent topics in Floryne O. Buishand's work include Neuroendocrine Tumor Research Advances (9 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Neuroblastoma Research and Treatments (3 papers). Floryne O. Buishand is often cited by papers focused on Neuroendocrine Tumor Research Advances (9 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Neuroblastoma Research and Treatments (3 papers). Floryne O. Buishand collaborates with scholars based in Netherlands, United States and United Kingdom. Floryne O. Buishand's co-authors include Jolle Kirpensteijn, Marja Kik, Jan A. Mol, Lisa Y. Pang, D. J. Argyle, Sebastiaan A. van Nimwegen, Ernst‐Jan M. Speel, Ger J. A. Arkesteijn, Inge H. Briaire‐de Bruijn and Electron Kebebew and has published in prestigious journals such as Scientific Reports, Carcinogenesis and Surgery.

In The Last Decade

Floryne O. Buishand

14 papers receiving 208 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Floryne O. Buishand Netherlands 10 116 92 65 63 53 14 218
Hirotaka Ishida Japan 11 151 1.3× 109 1.2× 95 1.5× 93 1.5× 107 2.0× 53 349
Min Cui United States 6 156 1.3× 84 0.9× 111 1.7× 72 1.1× 23 0.4× 17 247
Dominik Wiese Germany 11 200 1.7× 180 2.0× 58 0.9× 21 0.3× 56 1.1× 15 273
Claudia Manini Italy 7 76 0.7× 41 0.4× 56 0.9× 92 1.5× 50 0.9× 32 206
Michael Schvimer Israel 10 40 0.3× 33 0.4× 28 0.4× 14 0.2× 59 1.1× 20 194
F. Messeguer Spain 8 64 0.6× 102 1.1× 30 0.5× 28 0.4× 21 0.4× 30 216
Justin T. Gerstle United States 5 88 0.8× 38 0.4× 25 0.4× 18 0.3× 70 1.3× 11 169
Matilde Monti Italy 10 212 1.8× 126 1.4× 69 1.1× 48 0.8× 17 0.3× 13 365
Max H. Cohen United States 10 149 1.3× 38 0.4× 37 0.6× 32 0.5× 200 3.8× 15 389

Countries citing papers authored by Floryne O. Buishand

Since Specialization
Citations

This map shows the geographic impact of Floryne O. Buishand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Floryne O. Buishand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Floryne O. Buishand more than expected).

Fields of papers citing papers by Floryne O. Buishand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Floryne O. Buishand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Floryne O. Buishand. The network helps show where Floryne O. Buishand may publish in the future.

Co-authorship network of co-authors of Floryne O. Buishand

This figure shows the co-authorship network connecting the top 25 collaborators of Floryne O. Buishand. A scholar is included among the top collaborators of Floryne O. Buishand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Floryne O. Buishand. Floryne O. Buishand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
O’Neill, Dan G., et al.. (2025). Incidence and risk factors for insulinoma diagnosed in dogs under primary veterinary care in the UK. Scientific Reports. 15(1). 2463–2463. 1 indexed citations
2.
Buishand, Floryne O.. (2022). Current Trends in Diagnosis, Treatment and Prognosis of Canine Insulinoma. Veterinary Sciences. 9(10). 540–540. 10 indexed citations
3.
Buishand, Floryne O., et al.. (2020). Transcriptomic analysis by RNA sequencing characterises malignant progression of canine insulinoma from normal tissue to metastatic disease. Scientific Reports. 10(1). 11581–11581. 8 indexed citations
4.
Buishand, Floryne O., Yi Liu‐Chittenden, Yu Fan, et al.. (2019). Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy. Surgery. 167(1). 224–232. 13 indexed citations
5.
Wangsa, Darawalee, Rüdiger Braun, E. Michael Gertz, et al.. (2018). The evolution of single cell-derived colorectal cancer cell lines is dominated by the continued selection of tumor-specific genomic imbalances, despite random chromosomal instability. Carcinogenesis. 39(8). 993–1005. 20 indexed citations
6.
Buishand, Floryne O., et al.. (2018). Utility of contrast-enhanced computed tomography in the evaluation of canine insulinoma location. Veterinary Quarterly. 38(1). 53–62. 21 indexed citations
7.
Buishand, Floryne O., et al.. (2017). Notch pathway inhibition targets chemoresistant insulinoma cancer stem cells. Endocrine Related Cancer. 25(2). 131–144. 31 indexed citations
8.
Buishand, Floryne O., et al.. (2017). Trichostatin A preferentially reverses the upregulation of gene‐expression levels induced by gain of chromosome 7 in colorectal cancer cell lines. Genes Chromosomes and Cancer. 57(1). 35–41. 5 indexed citations
9.
Buishand, Floryne O., et al.. (2016). Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas. Stem Cells and Development. 25(11). 826–835. 22 indexed citations
10.
Buishand, Floryne O., Marja Kik, Andrea Gröne, et al.. (2014). Evaluation of prognostic indicators using validated canine insulinoma tissue microarrays. The Veterinary Journal. 201(1). 57–63. 14 indexed citations
11.
Buishand, Floryne O., et al.. (2013). Gene expression profiling of primary canine insulinomas and their metastases. The Veterinary Journal. 197(2). 192–197. 12 indexed citations
12.
Buishand, Floryne O., Jan A. Mol, Marja Kik, et al.. (2011). Expression of insulin-like growth factor-1 by canine insulinomas and their metastases. The Veterinary Journal. 191(3). 334–340. 8 indexed citations
13.
Buishand, Floryne O., et al.. (2011). Use of a bipolar vessel‐sealing device in resection of canine insulinoma. Journal of Small Animal Practice. 52(3). 139–145. 24 indexed citations
14.
Buishand, Floryne O., Marja Kik, & Jolle Kirpensteijn. (2010). Evaluation of clinico-pathological criteria and the Ki67 index as prognostic indicators in canine insulinoma. The Veterinary Journal. 185(1). 62–67. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirotaka Ishida Breakdown of academic impact, for papers by Min Cui Breakdown of academic impact, for papers by Dominik Wiese Breakdown of academic impact, for papers by Claudia Manini Breakdown of academic impact, for papers by Michael Schvimer Breakdown of academic impact, for papers by F. Messeguer Breakdown of academic impact, for papers by Justin T. Gerstle Breakdown of academic impact, for papers by Matilde Monti Breakdown of academic impact, for papers by Max H. Cohen
Rankless by CCL
2026